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Background: Although depression and anxiety have been implicated in risk for major adverse cardiovascular and
cerebrovascular events (MACCE), a theoretical approach to identifying such putative links is lacking. The objective of
this study was to examine the association between theoretical conceptualisations of depression and anxiety with
MACCE at the diagnostic and symptom dimension level.
Methods: Before coronary artery bypass graft (CABG) surgery, patients (N = 158; 20.9 % female) underwent a structured
clinical interview to determine caseness for depression and anxiety disorders. Depression and anxiety disorders were
arranged into the distress cluster (major depression, dysthymia, generalized anxiety disorder, post-traumatic stress
disorder) and fear cluster (panic disorder, agoraphobia, social phobia). Patients also completed the self-report
Mood and Anxiety Symptom Questionnaire, measuring anhedonia, anxious arousal and general distress/negative
affect symptom dimensions. Incident MACCE was defined as fatal or non-fatal; myocardial infarction, unstable
angina pectoris, repeat revascularization, heart failure, sustained arrhythmia, stroke or cerebrovascular accident, left
ventricular failure and mortality due to cardiac causes. Time-to-MACCE was determined by hazard modelling after
adjustment for EuroSCORE, smoking, body mass index, hypertension, heart failure and peripheral vascular disease.
Results: In the total sample, there were 698 cumulative person years of survival for analysis with a median follow-up of
4.6 years (interquartile range 4.2 to 5.2 years) and 37 MACCE (23.4 % of total). After covariate adjustment, generalized
anxiety disorder was associated with MACCE (hazard ratio [HR] = 2.79, 95 % confidence interval [CI] 1.00-7.80, p = 0.049).
The distress disorders were not significantly associated with MACCE risk (HR = 2.14; 95 % CI .92-4.95, p = 0.077) and
neither were the fear-disorders (HR = 0.24, 95 % CI .05-1.20, p = 0.083). None of the symptom dimensions were
significantly associated with MACCE.
Conclusions: Generalized anxiety disorder was significantly associated with MACCE at follow-up after CABG surgery.
The findings encourage further research pertaining to generalized anxiety disorder, and theoretical conceptualizations
of depression, general distress and anxiety in persons undergoing CABG surgery.
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Depression dominates recent understandings of the puta-
tive links between negative emotions and major adverse
cardiovascular and cerebrovascular events (MACCE, e.g.
myocardial infarction, stroke) in patients with coronary
heart disease (CHD) [1]. However, despite depression
treatment with psychotherapy and antidepressant inter-
ventions [2, 3], a consistent reduction in MACCE remains
elusive in the population with comorbid depression and
CHD [3], raising questions about the focus of interven-
tions [4]. Indeed, depression is but one of a spectrum of
disorders (e.g. anxiety, post-traumatic stress disorder and
panic disorder) which are purported to deleteriously affect
CHD outcomes [5–9]. In fact, most negative emotional
risk factors for MACCE share a common predisposition
to negative affectivity (NA), also known as neuroticism,
evident at both the theoretical [10, 11] and measurement
level [12–14]. Past attempts to clarify the risk of MACCE
attributable to depression independent of NA and anxiety
have not been consistently supported [12, 15–19], and a
theoretical approach to this field is lacking [13]. Therefore
the aim of this study is to utilize theoretical conceptua-
lizations of depression, NA and anxiety at the diagnostic
disorder, cluster and symptom level. Such theoretical con-
ceptualizations will, in turn, be employed to predict the
prognostic MACCE outcome in a sample of patients
undergoing coronary artery bypass graft (CABG) surgery.
Contemporary understandings of psychiatric nomen-
clature indicate that NA is the most ubiquitous feature
of depression and anxiety disorders [10, 20–23]. Beyond
the NA commonality, recent research also shows that
certain depression and anxiety disorders relate more
strongly to each other, and do not necessarily fall within
prescribed diagnostic categories of anxiety and depres-
sion. Specifically, previous empirical work largely sup-
ports a theoretical model with at least two groups of
affective disorders. The first is collectively labelled the
distress disorders and is comprised by major depression,
dysthymia, post-traumatic stress disorder and general-
ized anxiety disorder (GAD) [10, 20–24]. Research also
supports that symptoms of anhedonia are a dimensional
marker for the distress disorders, and therefore, not only
for major depression [10]. The second group of disor-
ders are collectively labeled the fear disorders which is
comprised of panic disorder, agoraphobia and social
phobia [10, 20–24]. Symptoms of anxious arousal are a
dimensional marker for the fear disorders [10], and
therefore, not for other traditional anxiety disorders such
as obsessive-compulsive disorder and post-traumatic
stress disorder.
Along these lines, prior research in CHD populations
has most commonly examined uni-polar and dysthymic
depression subtypes [25–27] and anhedonia in relation
to MACCE [28–31]. Also, some evidence in CHDpopulations suggests that post-traumatic stress disorder
is associated with MACCE recurrence [32]. By contrast,
GAD findings are more mixed [33–35] and there are too
few studies on other anxiety disorder subtypes [36]. We
are only aware of one study that assess anhedonia con-
temporaneously with anxious arousal and NA dimen-
sions of the distress and fear clusters [37]. With these
limitations in mind, we sought to extend the analysis of
MACCE to 4.6 year follow-up. Based on the predomin-
ant research to date, we hypothesized that the distress
disorder cluster and major depression especially would
be significantly associated with MACCE at follow-up.
Secondly, we hypothesized that the anhedonia dimen-
sion would be significantly associated with MACCE at
follow-up.
Method
Patients
Informed consent and ethics approval was obtained for
this study (The University of Adelaide Human Research
Ethics Committee approval # H-010-2007, The Flinders
Medical Centre Human Research Ethics Committee ap-
proval 112/067) and the methods have been reported
previously [37, 38]. Briefly, recruitment took place at the
Flinders Medical Centre, South Australia, between
February 2007 and March 2009. Patients were consid-
ered eligible if aged ≥ 18 years and undergoing CABG
with cardiopulmonary bypass, and with or without con-
comitant valve procedures. From 252 eligible patients 84
patients were ineligible: declined (n = 23), communica-
tion difficulty (n = 4), participating in another research
trial (n = 10), health reasons (n = 2), developmental dis-
order (n = 2), dementia (n = 1), living in a remote com-
munity with no contact details (n = 11), late addition to
surgical list (n = 2), on the hospital ward <24 h (n = 16),
time constraints/admitted on weekend (n = 13). From
252 eligible patients we recruited 168 and 10 patients
were excluded further: surgery postponed indefinitely
(n = 1), withdrawal of consent (n = 1), current psychosis
and/or taking anti-psychotic medications (n = 3), current
or past alcohol and/ or substance abuse (n = 5). This left
a total sample of 158 patients (63 % participation rate).
A flow chart of participants through the study is shown
in Fig. 1. Non-respondents and excluded patients were
more likely to identify as Aboriginal or Torres Strait
Islander χ2 (1) = 5.85, p = .02 but were otherwise not dis-
crepant from participants on baseline demographic and
comorbid conditions. Medical data were prospectively
collected by medical officers at pre-surgical consultation
and entered directly onto an electronic database with
quality assurance maintained at weekly database meet-
ings by the third author. Data definitions utilize those of
the Australian Society of Cardiac and Thoracic Surgeons
[39] including permanent stroke, cerebrovascular accident
Fig. 1 Flow chart of participants through the study. Graph showing selection and attrition of participants through the study. CABG, coronary
artery bypass graft surgery; MACCE, major adverse cardiovascular and cerebrovascular events; MINI, MINI International Psychiatric Interview
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72 h, myocardial infarction (2 or more of: enzyme level
elevation; new wall motion abnormalities; serial EGG
showing new Q waves).
Structured interview
Patients were assessed a median of 3 days preoperatively
(interquartile range 1–3 days). The MINI International
Neuropsychiatric Interview (MINI) 5.0.0 [40, 41] was
employed to determine psychiatric disorders by an
intern psychologist (first author, with 1,000 h clinical
psychology experience, employed 0.4 full-time equivalent
in the study hospital). The MINI has high sensitivity and
specificity to detect current mood and anxiety disorders,
with Kappa coefficients (κ = .86 - .96) suggesting favor-
able agreement with Diagnostic and Statistical manual of
Mental Disorders-IV (DSM-IV) [40, 42]. The MINI hier-
archical diagnostic criteria stipulate that a GAD diagno-
sis cannot be made with a concurrent major depression
diagnosis thus precluding comorbidity of these disorders
and providing the advantage of classifying only primary
affective disorders. Disorders were arranged into the dis-
tress cluster (major depression, dysthymia, post-traumatic
stress disorder and GAD) and the fear disorder cluster
(panic disorder, agoraphobia, and social phobia). Wealso considered affective disorders with more than 10 %
prevalence at baseline as candidates for analysis in rela-
tion to MACCE.
Self-report sistress assessments
Mood and anxiety symptom questionnaire
The self-report mood and anxiety symptom question-
naire (MASQ) was used to measure anhedonia, anxious
arousal and general NA [43]. Based on the work of
Wardenaar et al. [44, 45], we constructed a 30-item
short form where 10-items each are allocated to an anx-
ious arousal, anhedonia/low positive affect and general
NA scale. Example items of anxious arousal include
“Was trembling or shaking”; “Had hot or cold spells”.
The anhedonic depression scale utilizes reverse-keyed
items assessing positive emotional experiences including
“Felt like I had a lot to look forward to”; “Felt like I was
having a lot of fun”. Example items of the MASQ-
general NA scale include “Felt irritable”; “Worried a lot
about things”. The MASQ has been found to fit the
three-dimensional model (general NA, anhedonia, anx-
ious arousal) indicating good construct validity with high
discriminant validity [44], and was recently validated in
the English language [46]. Previous psychometric research
with the MASQ has established good psychometric
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present sample satisfactory internal consistency was ob-
served (Cronbach’s alpha coefficients; general NA =
0.88; anhedonia = 0.84; anxious arousal = 0.77).
Major adverse cardiovascular and cerebrovascular events
The Australian Institute of Health and Welfare’s National
Death Index was utilized to determine mortality data until
the study census date 31st December 2013, according to
the International Classification of Diseases (ICD) 10th
Revision codes [53]. Hospital admission after discharge
from the index CABG procedure was ascertained from pa-
tient medical records and electronic admission data linkage
between hospitals in ICD code [53]. The MACCE endpoint
was defined as fatal or non-fatal hospitalisation for myocar-
dial infarction, unstable angina pectoris, repeat revasculari-
zation, sustained arrhythmia, stroke or cerebrovascular
accident, heart failure, left ventricular failure and mortality
due to cardiac causes, as consistent with previous research
[54]. In this manner, any non-cardiac death is censored
from the analyses at the date of death. All MACCE were
inspected blinded to psychological distress scores.
Statistical analysis
Data analysis was performed with SPSS® 22.0 statistical
software package (SPSS Inc., Chicago, IL). Descriptive
comparisons were made with the t-test, the chi-square
test or the Fisher’s exact test as appropriate. All statis-
tical tests were two-tailed, an alpha value p ≤ .05 was
considered statistically significant, and no adjustment
was made for multiple comparisons based on the recom-
mendations of Rothman [55]. Adjusted Cox proportional
model hazard ratios (HR) and 95 % confidence intervals
(CIs) were used to determine the risk of MACCE associ-
ated with negative emotions. Candidate covariates for
hazard models were selected a priori based on the litera-
ture to cover the covariates that are associated with
depression and anxiety (independent variables) [56]. We
also selected covariates associated with MACCE risk and
cardiac surgery morbidity outcomes (dependent vari-
ables) [57, 58]. The candidate covariates included smok-
ing, body mass index, hypertension, heart failure,
peripheral vascular disease, and the European System for
Cardiac Operative Risk Evaluation [59] (EuroSCORE).
The EuroSCORE is calculated from 17 risk factors
including age, sex, left ventricular dysfunction, previous
cardiac surgery, elevated creatinine and concomitant
procedures among others, and is associated with
MACCE and survival in the long-term [57, 58]. The
proportionality of hazards assumption was checked ini-
tially by entering covariates as interactions with time
and also ascertained graphically in final models via
examination of the log-minus-log plot of survival func-
tion, and the Schoenfield residuals.We examined the associations between clusters, disor-
ders and symptom dimensions with future MACCE in
three respective models. Model 1 was comprised of co-
variates and the diagnostic categories of prevalent
affective disorders (GAD, panic disorder and major de-
pression). Model 2 was comprised of covariates and the
affective disorders were arranged into distress and fear
clusters. Model 3 concerned the symptom dimensions of
anhedonia, anxious arousal and general NA as measured
with the MASQ.
Results
Descriptive characteristics
The final sample consisted of 158 CABG patients be-
tween 36 and 87 years (mean age = 64.7 years ± 10.6,
20.9 % women, 11.4 % concomitant valve surgery). Base-
line characteristics stratified by MACCE are shown in
Table 1. Patients experiencing a MACCE were signifi-
cantly older and were characterized by a higher propor-
tion of hypertension, heart failure and peripheral
vascular disease. In the total sample, there were 698 cu-
mulative person years of survival for analysis with a me-
dian follow-up of 4.6 years (interquartile range 4.2 to
5.2). There were 37 MACCE events (23.4 % of total),
most commonly deaths due to CHD (n = 15), and non-
fatal myocardial infarction (n = 13), incident heart failure
(n = 5) and stroke (n = 4).
Prevalence of affective disorders
Diagnostic interview indicated that major depression
was most common (n = 27, 17.1 %), followed by panic
disorder (n = 12, 10.8 %) and GAD (n = 16, 10.2 %). In
total, there were 39 (24.7 %) patients meeting at least
one diagnosis of the distress cluster and 21 (13.3 % of
total) participants meeting criteria from the fear cluster.
Risk factors for major adverse cardiovascular events
Examination of the affective disorders, clusters and symp-
tom dimensions are shown in Table 2. Model 1 suggested
that only GAD was significantly associated with an in-
creased risk of MACCE (adjusted HR = 2.79, 95 % CI 1.00
to 7.80, p = .05). Fig. 2 depicts the divergence in cumula-
tive survival curves for MACCE in the period after CABG
according to GAD status before surgery and is evident
within the first year. Neither depression nor panic disorder
was associated with MACCE (both p >. 20).
[Model 2 shows the association between the distress
disorders and MACCE (adjusted HR = 2.14, 95 % CI .92 to
4.95, p = .08) and the fear disorders and MACCE (adjusted
HR = .24, 95 % CI .05 to 1.20, p = .08). Although both
associations were above conventional significance, there
was a trend for an increased risk for MACE associated
with the distress disorders and a reduced risk associated
with the fear disorders.
Table 1 Baseline characteristics of patients with and without a MACCE after CABG surgery
Descriptive variables Total N (%)a No MACCE (n = 121) MACCE (n = 37) P
Age, M ± SD 64.7 ± 10.6 63.7 ± 10.5 67.8 ± 10.4 .04
Female 33 (20.9) 26 (21.5) 7 (18.9) .74
Aboriginal 6 (3.8) 3 (2.5) 3 (8.1) .14
BMI, M ± SD 29.1 ± 5.2 29.3 ± 5.0 28.6 ± 5.6 .47
Concomitant valvular procedure 18 (11.4) 12 (9.9) 6 (16.2) .29
Urgent surgery 34 (21.5) 28 (23.1) 6 (16.2) .37
Previous MI <30 days 51 (32.3) 39 (32.2) 12 (32.4) .98
LVEF 45 – 60 % 33 (20.9) 22 (18.2) 11 (29.7) .39
30 – 45 % 12 (7.4) 9 (7.4) 3 (8.1)
<30 % 6 (3.3) 4 (3.3) 2 (5.4)
Hypertension 102 (64.6) 73 (60.3) 29 (78.4) .04
Hypercholesterolemia 118 (74.7) 91 (75.2) 27 (73.0) .79
Diabetes, Type 1 2 (1.3) 2 (1.7) - .63
Type 2 48 (30.4) 38 (31.4) 10 (27.0)
Chronic lung disease 33 (20.9) 27 (22.3) 6 (16.2) .43
Renal disease 11 (7.0) 6 (5.0) 5 (13.5) .07
Heart failure 40 (25.3) 26 (21.5) 14 (37.8) .04
Peripheral vascular disease 18 (11.4) 10 (8.3) 8 (21.6) .03
Cerebrovascular disease 16 (10.1) 12 (9.9) 4 (10.8) .88
Tobacco smoking 94 (59.5) 73 (60.3) 21 (56.8) .70
SSRI 6 (3.8) 4 (3.3) 2 (5.4) .63
Tricyclic 3 (1.9) 1 (0.8) 2 (5.4) .14
Aspirin 122 (77.2) 91 (75.2) 31 (83.8) .28
EuroSCORE, Median (IQR) 2.6 (1.5 – 4.7) 2.5 (1.5 – 4.4) 3.1 (2.0 – 6.6) .24
Pre-CPB Hb, M ± SD 13.9 ± 1.7 14.0 ± 1.7 13.5 ± 2.0 .17
Minutes spent on CPB Median (IQR) 56.0 (42.8 – 73.0) 57.0 (46.0 – 73.0) 52.0 (36.5 – 74.5) .30
ICU LOS, median hours (IQR) 25.7 (23 – 47.5) 25.7 (23.0 – 48.4) 25.7 (23.6 – 27.6) .97
ICU intubation, median hours (IQR) 12.5 (10.1 – 17.0) 12.2 (9.6 – 16.4) 14.2 (11.5 – 22.0) .13
aData presented as N (%) unless otherwise specified
BMI body mass index, CABG coronary artery bypass graft surgery, CPB cardiopulmonary bypass, ICU intensive care unit, IQR interquartile range, LVEF left ventricular
ejection fraction, LOS length of stay, M± SD mean ± standard deviation, MACCE major adverse cardiovascular and cerebrovascular events, MI myocardial infarction,
SSRI selective serotonin re-uptake inhibitor
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general NA were not associated with MACCE (all p >. 30).
Covariates significantly associated with MACCE in
Models 1 to 3 included heart failure (HR 2.31 to 2.40) and
EuroSCORE (HR 1.05 to 1.06).
Sensitivity analyses
Considering that there was a significant association
between GAD and MACCE, but a relatively limited
number of MACCE, we performed sensitivity analyses
showing the change in effect size attributable to GAD
with adjustment for each individual covariate. This ana-
lytical strategy involved entering only a single covariate
into the GAD model. This approach has been adopted
previously [35] and is less prone to overfitting the Coxregression model. The results indicated that a 5 % change
in the GAD-MACCE hazard ratio was evident for panic
disorder, hypertension and tobacco smoking, though GAD
remained significantly associated with MACCE (Table 3).
In our second sensitivity analysis, we assessed whether
theoretical conceptualizations of depression and anxiety
were associated with the acute cardiovascular events of
myocardial infarction and cardiac death (combined n = 28).
In unadjusted analyses, it was evident that only GAD
was related to acute cardiovascular events (unadjusted
HR = 2.92, 95 % CI 0.98 to 8.64, p = .054).
Discussion
This study was the first to comprehensively examine the
MACCE risk attributable to affective disorders at the
Table 2 Hazard ratios for MACcE after CABG according to affective disorders, disorder clusters, and symptom dimensions
Model structure N (%)a Hazard ratiob 95 % CI lower 95 % CI upper P
Model 1: Diagnostic Level - Disorders
Generalized Anxiety Disorder 16 (10.2) 2.79 1.00 7.80 .049
Major Depression 27 (17.1) 1.04 .40 2.67 .94
Panic Disorder 12 (10.8) .36 .08 1.76 .21
Model 2: Theoretical Level - Disorder Clusters
Distress disordersc 39 (24.7) 2.14 .92 4.95 .08
Fear disordersd 21 (13.3) .24 .05 1.20 .08
Model 3: Theoretical Level - Symptom Dimensions
MASQ General Negative Affect 19.1 ± 3.0 1.07 .89 1.30 .46
MASQ Anhedonia 16.5 ± 3.2 1.04 .85 1.26 .73
MASQ Anxious Arousal 22.8 ± 4.5 .94 .84 1.06 .30
CABG coronary artery bypass graft, CI confidence interval, HR hazard ratio, MACCE major adverse cardiovascular and cerebrovascular events, MASQ Mood and
Anxiety Symptom Questionnaire
aThe M ± SD is reported for MASQ General Negative Affect, Anhedonia and Anxious Arousal
bHazard model adjusted for EuroSCORE, smoking, body mass index, hypertension, heart failure, peripheral vascular disease
cMisery cluster comprised by major depression, dysthymia, generalized anxiety disorder and post-traumatic stress disorder
dFear disorder cluster comprised by panic disorder, agoraphobia, social phobia
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cohort of CHD patients undergoing CABG surgery. At
the diagnostic level, it was evident that GAD was
significantly associated with MACCE after cardiac
surgery, extending previous findings among CHD out-
patients [33, 35]. With respect to the arrangement of
disorders into clusters, it was evident that the distress
disorders were not significantly associated with in-
creased MACCE risk, and therefore not supporting the
hypothesis. The symptom dimensions anhedonia and
anxious arousal were not significantly associated with
MACCE, thus not supporting the hypothesis nor previ-
ous work [30, 31].
The study showed no significant association between
MACCE and the distress or fear disorders, their symp-
tom dimensions, panic disorder or major depression.
Nonetheless, the GAD findings align with some larger
studies [33, 35], albeit contrasting to Parker and col-
leagues’ cohort [34]. Previously in a large epidemiological
survey, Goodwin and colleagues [60] showed that GAD
was most strongly associated with lower CHD risk in
cross-sectional analyses whereas the mood disorders
were not. Potential mechanisms underlying the associ-
ation with CHD include GAD patients’ propensity to-
ward diminished heart rate variability [61], elevated
heart rate, smoking, and hypertension [62], parallel to
what has been reported amongst depressed CHD and
CABG surgery patients [63–66]. Our arrangement of
disorders into the distress cluster, inclusive of GAD and
depression, did not show a significant association with
MACCE (p = .08). However, this finding was possibly
limited by the infrequent occurrence of other disorders
especially dysthymia and post-traumatic stress disorder,considering that an emerging literature documents an
association between these disorders and MACCE in
CHD populations [25, 27, 67].
When symptom dimensions were examined, there was
no significant association between MASQ anhedonia, anx-
ious arousal or general NA with subsequent MACCE. The
findings with respect to anhedonia contrast to Denollet
and colleagues study [28] which reported that a four-item
anhedonia measure was associated with MACCE in percu-
taneous coronary intervention patients. Also, Leroy and
colleagues’ study [31] showed that the Chapman Physical
Anhedonia Scale was associated with twofold increase in
MACCE at 3-year follow-up after acute coronary syn-
drome. Further assessment of the anhedonia symptom
dimension may provide insight as to specific underlying
mechanisms linking depression and MACCE. For ex-
ample, the anhedonia symptom dimension is highly asso-
ciated with biological mechanisms of cardiopathogenesis
such as the hypothalamus-pituitary-adrenal axis [68] and
the metabolic syndrome [69]. Moreover, symptom dimen-
sions are also associated with other risk factors for cardio-
pathogenesis such as exposure to childhood trauma, social
disadvantage, and adversity in adult life [70].
The current findings may have clinical relevance for
the population with GAD who are facing CABG sur-
gery, or comorbid CHD and anxiety disorders generally
[71]. Specifically, the findings raise the possibility that
psychological interventions targeting GAD are war-
ranted in CABG surgery patients. Recently it was shown
that collaborative care programs were effective for a
reduction in generalized anxiety and depression symp-
toms [72, 73]. Moreover, exercise, anxiolytic use and
cognitive behavioral therapy for GAD were associated
Table 3 Change in the strength of association between
generalized anxiety disorder and major adverse cardiovascular
events after adjustment for potential confounders
Model covariates Change in GAD hazard ratio
after adjustment, %
Depression disorder 1.6
Panic disorder 5.7
EuroSCORE 3.3
Heart failure 4.2
Hypertension −8.3
Peripheral vascular disease −0.3
Body mass index 1.5
Smoking 7.1
GAD, generalized anxiety disorder
Fig. 2 Cox Hazard model survival graph of cumulative survival after CABG surgery until MACCE according to GAD status. Graph showing cumulative
survival curves for MACCE comparing patients according to preoperative GAD diagnosis. Dotted line represents no GAD before CABG surgery (n = 142)
and the solid black line represents a diagnosis of GAD before CABG surgery (n = 16, adjusted hazard ratio 2.79, 95 % confidence interval 1.00 – 7.80,
p = .05). Adjustment made for EuroSCORE, smoking, body mass index, hypertension, heart failure, peripheral vascular disease. CABG, coronary artery
bypass graft surgery; GAD, generalized anxiety disorder; MACCE, major adverse cardiovascular and cerebrovascular events
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among persons with comorbid depression disorder-
GAD and heart failure [74]. In the population undergo-
ing CABG surgery, prior interventions have indicated
small to medium treatment effect sizes regarding reduc-
tion in depression and anxiety symptoms [75–78].
Moreover, non-pharmacological intervention is espe-
cially advantageous in the CABG population given that
selective serotonin re-uptake inhibitors may pose a
morbidity risk particularly relating to postoperative
hemorrhage [79–81].
This study’s main methodological strength is the
delineation of disorders at the diagnostic and cluster
level and the measurement of symptom dimensions.
There are several limitations to the generalizability of
these results including that the psychiatric assessment
occurred before CABG surgery. It cannot be ruled out
that some persons experienced a worsening of their
mental health postoperatively and possibly developed
Tully et al. BioPsychoSocial Medicine  (2015) 9:14 Page 8 of 10psychiatric comorbidities not quantified in this study.
Furthermore, we were not able to identify persons re-
ceiving treatment for mental disorders after CABG sur-
gery which may affect the occurrence of MACCE [82]. It
is also possible too that anxiety levels were especially
higher than normal in the CABG patients during the
pre-operative period. With respect to psychiatric comor-
bidity that is common in persons with depression, we
cannot extend our findings to the externalizing cluster
of disorders [24], as patients with alcohol and substance
abuse were excluded. Also, low base rates were observed
for some disorders. Moreover, hierarchical exclusion
rules stipulated by the MINI preclude comorbidity be-
tween these disorders and would inevitably result in
lower depression and GAD prevalence. Consequently,
analysis of cardiac morbidity was constrained to a com-
bined MACCE endpoint with adjustment for a limited
number of covariates. Indeed, the width of the confi-
dence intervals suggests that future studies may benefit
from larger samples. Finally, the participation rate was
under-represented by Indigenous Australian peoples
partly because persons living in rural and remote areas
without a fixed residential address were excluded. As
lower access to medical services may disadvantage Indi-
genous Australian peoples with CHD [83], the findings
may not generalize to these cultural groups.
In conclusion, analysis with various theoretical con-
ceptualizations of negative emotions suggested that
only GAD was significantly associated with MACCE
after CABG surgery. The non-significant association
between MACCE and the distress-cluster may warrant
further investigation in larger samples. Further research
concerning combinations of disorders and negative
emotions may contribute to clinical intervention in the
population with CHD.
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